User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

The anti-CD20 antibody rituximab reduces the Th17 cell response.

  1. Edwards Jonathan C.W., Szczepański Leszek, Szechiński Jacek, Filipowicz-Sosnowska Anna, Emery Paul, Close David R., Stevens Randall M., Shaw Tim, Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis, 10.1056/nejmoa032534
  2. Tsokos George C., B Cells, Be Gone — B-Cell Depletion in the Treatment of Rheumatoid Arthritis, 10.1056/nejmp048114
  3. Hauser Stephen L., Waubant Emmanuelle, Arnold Douglas L., Vollmer Timothy, Antel Jack, Fox Robert J., Bar-Or Amit, Panzara Michael, Sarkar Neena, Agarwal Sunil, Langer-Gould Annette, Smith Craig H., B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis, 10.1056/nejmoa0706383
  4. McFarland Henry F., The B Cell — Old Player, New Position on the Team, 10.1056/nejmp0708143
  5. Ouyang Wenjun, Kolls Jay K., Zheng Yan, The Biological Functions of T Helper 17 Cell Effector Cytokines in Inflammation, 10.1016/j.immuni.2008.03.004
  6. Bettelli Estelle, Korn Thomas, Oukka Mohamed, Kuchroo Vijay K., Induction and effector functions of TH17 cells, 10.1038/nature07036
  7. Ikeuchi Hidekazu, Kuroiwa Takashi, Hiramatsu Noriyuki, Kaneko Yoriaki, Hiromura Keiju, Ueki Kazue, Nojima Yoshihisa, Expression of interleukin-22 in rheumatoid arthritis: Potential role as a proinflammatory cytokine, 10.1002/art.20965
  8. Kebir Hania, Kreymborg Katharina, Ifergan Igal, Dodelet-Devillers Aurore, Cayrol Romain, Bernard Monique, Giuliani Fabrizio, Arbour Nathalie, Becher Burkhard, Prat Alexandre, Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation, 10.1038/nm1651
  9. Arnett Frank C., Edworthy Steven M., Bloch Daniel A., Mcshane Dennis J., Fries James F., Cooper Norman S., Healey Louis A., Kaplan Stephen R., Liang Matthew H., Luthra Harvinder S., Medsger Thomas A., Mitchell Donald M., Neustadt David H., Pinals Robert S., Schaller Jane G., Sharp John T., Wilder Ronald L., Hunder Gene G., The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis, 10.1002/art.1780310302
  10. Prevoo M. L. L., Van'T Hof M. A., Kuper H. H., Van Leeuwen M. A., Van De Putte L. B. A., Van Riel P. L. C. M., Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis : MODIFIED DISEASE ACTIVITY SCORE, 10.1002/art.1780380107
  11. Lehrer, J Bacteriol, 98, 996 (1969)
  12. van der Graaf C. A. A., Netea M. G., Verschueren I., van der Meer J. W. M., Kullberg B. J., Differential Cytokine Production and Toll-Like Receptor Signaling Pathways by Candida albicans Blastoconidia and Hyphae, 10.1128/iai.73.11.7458-7464.2005
  13. Netea M. G., Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors, 10.1172/jci27114
  14. Stevens Emily A., Bradfield Christopher A., Immunology: T cells hang in the balance, 10.1038/453046a
  15. Nistala K., Wedderburn L. R., Th17 and regulatory T cells: rebalancing pro- and anti-inflammatory forces in autoimmune arthritis, 10.1093/rheumatology/kep028
  16. Wang R., Kozhaya L., Mercer F., Khaitan A., Fujii H., Unutmaz D., Expression of GARP selectively identifies activated human FOXP3+ regulatory T cells, 10.1073/pnas.0901965106
  17. Olsen Nancy J., Stein C. Michael, New Drugs for Rheumatoid Arthritis, 10.1056/nejmra032906
  18. Acosta-Rodriguez Eva V, Rivino Laura, Geginat Jens, Jarrossay David, Gattorno Marco, Lanzavecchia Antonio, Sallusto Federica, Napolitani Giorgio, Surface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells, 10.1038/ni1467
  19. van de Veerdonk Frank L., Marijnissen Renoud J., Kullberg Bart Jan, Koenen Hans J.P.M., Cheng Shih-Chin, Joosten Irma, van den Berg Wim B., Williams David L., van der Meer Jos W.M., Joosten Leo A.B., Netea Mihai G., The Macrophage Mannose Receptor Induces IL-17 in Response to Candida albicans, 10.1016/j.chom.2009.02.006
  20. Shahrara Shiva, Huang QiQuan, Mandelin Arthur M, Pope Richard M, TH-17 cells in rheumatoid arthritis, 10.1186/ar2477
  21. Tzartos John S., Friese Manuel A., Craner Matthew J., Palace Jackie, Newcombe Jia, Esiri Margaret M., Fugger Lars, Interleukin-17 Production in Central Nervous System-Infiltrating T Cells and Glial Cells Is Associated with Active Disease in Multiple Sclerosis, 10.2353/ajpath.2008.070690
  22. Algino Kenneth M., Thomason Ronald W., King David E., Montiel Milka M., Craig Fiona E., CD20 (Pan-B Cell Antigen) Expression on Bone Marrow-Derived T Cells, 10.1093/ajcp/106.1.78
  23. Esensten, Nat Rev, 5, 560 (2009)
  24. Yamada H, Nakashima Y, Okazaki K, Mawatari T, Fukushi J-I, Kaibara N, Hori A, Iwamoto Y, Yoshikai Y, Th1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritis, 10.1136/ard.2007.080341
  25. Hillyer P., Larche M. J., Bowman E. P., McClanahan T. K., de Waal Malefyt R., Schewitz L. P., Giddins G., Feldmann M., Kastelein R. A., Brennan F. M., Investigating the role of the interleukin-23/-17A axis in rheumatoid arthritis, 10.1093/rheumatology/kep293
  26. Milner Joshua D., Brenchley Jason M., Laurence Arian, Freeman Alexandra F., Hill Brenna J., Elias Kevin M., Kanno Yuka, Spalding Christine, Elloumi Houda Z., Paulson Michelle L., Davis Joie, Hsu Amy, Asher Ava I., O’Shea John, Holland Steven M., Paul William E., Douek Daniel C., Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome, 10.1038/nature06764
  27. Van den Berg, Nat Rev, 5, 549 (2009)
  28. Batista Facundo D., Harwood Naomi E., The who, how and where of antigen presentation to B cells, 10.1038/nri2454
  29. Dinarello, Blood, 77, 1627 (1991)
  30. Chung Yeonseok, Chang Seon Hee, Martinez Gustavo J., Yang Xuexian O., Nurieva Roza, Kang Hong Soon, Ma Li, Watowich Stephanie S., Jetten Anton M., Tian Qiang, Dong Chen, Critical Regulation of Early Th17 Cell Differentiation by Interleukin-1 Signaling, 10.1016/j.immuni.2009.02.007
  31. Leslie M., Take-Charge B Cells Create a Buzz, 10.1126/science.325_144
  32. Harris David P., Haynes Laura, Sayles Peter C., Duso Debra K., Eaton Sheri M., Lepak Nancy M., Johnson Lawrence L., Swain Susan L., Lund Frances E., 10.1038/82717
  33. Matthews R., The B Cell Slayer, 10.1126/science.318.5854.1232
Bibliographic reference van de Veerdonk, Frank L ; Lauwerys, Bernard ; Marijnissen, Renoud J ; Timmermans, Kim ; Di Padova, Franco ; et. al. The anti-CD20 antibody rituximab reduces the Th17 cell response.. In: Arthritis & Rheumatism, Vol. 63, no. 6, p. 1507-1516 (2011)
Permanent URL http://hdl.handle.net/2078.1/105515